Allergopharma Award 2015

Alexander eggelPresented at EAACI in Barcelona, the 7th of June 2015 to the winner, Dr. Alexander Eggel, based on the article

Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel et al, J Allergy Clin Immunol, 2014, Vol. 133, No. 6.

Dr. Eggel obtained his PhD degree at University of Bern in Switzerland and following a year as Postdoctoral Fellow at the University of Stanford, he returned to Bern and is currently Group Leader at the Institute of Immunology. Over the years, he has received several recognitions for outstanding work in the fields of allergy and immunology.

In several publications the focus of has been on IgE/IgE-receptor interactions. The awarded publication describes the action of a new class of IgE inhibitors with therapeutic potential acting by suppression of the allergic response of effector cells from sensitised individuals.Thereby this paper provides new knowledge as well as points at potential applications in present and future diagnostic and therapeutic regimens.

The winner of the PhARF Award 2015 is Joshua David Milner, MD, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, US. It was announced at the Opening Ceremony of the EAACI Congress in Barcelona 6 June.

cid:image001.jpg@01D09F78.2F6144A0

Dr Milner is an extraordinary young investigator, with an outstanding publication record whose exceptional originality and creativity has led to improved understanding of the genetics of atopic disease and pathophysiologic mechanisms revealed by genetic mutations. He has also identified potential therapeutic targets for mast cell diseases, which impact a variety of disorders.

Last updated 23 June 2015